Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo

Virology

Volumn 263, Issue 2, 1999, Pages 408-417

  Lichtenstein, Drew L ^a   Craigo, Jodi K ^a   Leroux, Caroline ^a   Rushlow, Keith E ^a   Cook, R Frank ^b   Cook, Sheila J ^b   Issel, Charles J ^b   Montelaro, Ronald C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ENHANCER REGION; EQUINE INFECTIOUS ANEMIA VIRUS; GENE SEQUENCE; LONG TERMINAL REPEAT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; RNA VIRUSES;

EID: 0033604278     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9921     Document Type: Article

References (42)

1. Carpenter S., Alexandersen S., Long M. J., Perryman S., Chesebro B. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J. Virol. 65:1991;1605-1610.
2. Carvalho M., Derse D. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter. J. Virol. 67:1993a;2064-2074.
3. Carvalho M., Derse D. The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter. J. Virol. 67:1993b;3885-3890.
4. Carvalho M., Kirkland M. M., Derse D. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity. J. Virol. 67:1993;6586-6595.
5. Coffin J. M. Genetic variation in avian retroviruses. Dev. Biol. Standard. 72:1990;123-132.
6. Cook R. F., Leroux C., Cook S. J., Berger S. L., Lichtenstein D. L., Ghabrial N. N., Montelaro R. C., Issel C. J. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J. Virol. 72:1998;1383-1393.
7. Corboy J. R., Garl P. J. HIV-1 LTR DNA sequence variation in brain-derived isolates. J. Neurovirol. 3:1997;331-341.
8. Derse D., Dorn P. L., Levy L., Stephens R. M., Rice N. R., Casey J. W. Characterization of equine infectious anemia virus long terminal repeat. J. Virol. 61:1987;743-747.
9. Genetics Computer Group, 1994, Program manual for the Wisconsin Package, Genetic Computer Group, Madison, WI.
10. Hussain K. A., Issel C. J., Schnorr K. L., Rwambo P. M., Montelaro R. C. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: Epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J. Virol. 61:1987;2956-2961.
11. Issel C. J., Horohov D. W., Lea D. F., Adams W. V. Jr., Hagius S. D., McManus J. M., Allison A. C., Montelaro R. C. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 66:1992;3398-3408.
12. Jamieson D. D., Aldrovandi G. M., Planelles V., Jowett J. B. M., Goa L. L., Bloch M. I., Chen S. Y., Zack J. A. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68:1994;3478-3485.
13. Kawakami T., Sherman L., Dahlberg J., Gazit A., Yaniv A., Tronick S. R., Aaronson S. A. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology. 158:1987;300-312.
14. Kestler H. W. I., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
15. Koken S. E., van Wamel J. L., Goudsmit J., Berkhout B., Geelen J. L. Natural variants of the HIV-1 long terminal repeat: Analysis of promoters with duplicated DNA regulatory motifs. Virology. 191:1992;968-972.
16. Kono Y., Kobayashi K., Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Virol. 41:1973;1-10.
17. Kono Y., Yokomizo Y. Propagation and titration of equine infectious anemia virus in horse leukocyte culture. Natl. Inst. Anim. Health Q. 7:1967;8-20.
18. Krebs F. C., Mehrens D., Pomeroy S., Goodenow M. M., Wigdahl B. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. J. Biomed. Sci. 5:1998;31-44.
19. Leroux C., Issel C. J., Montelaro R. C. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J. Virol. 71:1997;9627-9639.
20. Lichtenstein D. L., Issel C. J., Montelaro R. C. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus. J. Virol. 70:1996;3346-3354.
21. Lichtenstein D. L., Rushlow K. E., Cook R. F., Raabe M. L., Swardson C. J., Kociba G. J., Issel C. J., Montelaro R. C. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J. Virol. 69:1995;2881-2888.
22. Madden C. R., Shih D. S. Analysis of the long terminal repeat from a cytopathic strain of equine infectious anemia virus. Virology. 225:1996;395-399.
23. Maury W. Monocyte maturation controls expression of equine infectious anemia virus. J. Virol. 68:1994;6270-6279.
24. Maury W. Regulation of equine infectious anemia virus expression. J. Biomed. Sci. 5:1998;11-23.
25. Maury W., Perryman S., Oaks J. L., Seid B. K., Crawford T., McGuire T., Carpenter S. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus. J. Virol. 71:1997;4929-4937.
26. Montelaro R. C., Ball J. M., Rushlow K. E. Equine retroviruses. Levy J. The Retroviridae. 1993;257-360 Plenum, New York.
27. Montelaro R. C., Parekh B., Orrego A., Issel C. J. Antigenic variation during persistent infection by equine infectious anemia virus, a lentivirus. J. Biol. Chem. 259:1984;10539-10544.
28. Payne S. L., Rausch J., Rushlow K., Montelaro R. C., Issel C., Flaherty M., Perry S., Sellon D., Fuller F. Characterization of infectious molecular clones of equine infectious anemia virus. J. Gen. Virol. 75:1994;425-429.
29. Payne S. L., Rushlow K. E., Dhruva B. R., Issel C. J., Montelaro R. C. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoprotein using recombinant env-encoded protein fragments produced in Escherichia coli. Virology. 172:1989;609-615.
30. Payne S. L., Salinovich O., Nauman S. M., Issel C. J., Montelaro R. C. Course and extent of variation of equine infectious anemia virus during persistent infections. J. Virol. 61:1987;1266-1270.
31. Perry S. T., Flaherty M. T., Kelley M. J., Clabough D. L., Tronick S. R., Coggins L., Whetter L., Lengel C. R., Fuller F. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J. Virol. 66:1992;4085-4097.
32. Raabe M. R., Issel C. J., Cook S. J., Cook R. F., Woodson B., Montelaro R. C. Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from clinical disease to severe enhancement. Virology. 245:1998a;151-162.
33. Raabe M. R., Issel C. J., Montelaro R. C. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J. Virol. Methods. 71:1998b;87-104.
34. Rousseau C., Abrams E., Lee M., Urbano R., King M. C. Long terminal repeat and nef gene variants of human immunodeficiency virus type 1 in perinatally infected long-term survivors and rapid progressors. AIDS Res. Hum. Retroviruses. 13:1997;1611-1623.
35. Rwambo P. M., Issel C. J., Adams W. J. K., Hussain A., Miller M., Montelaro R. C. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Arch. Virol. 111:1990a;199-112.
36. Rwambo P. M., Issel C. J., Hussain K. A., Montelaro R. C. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus. Arch. Virol. 111:1990b;275-280.
37. Rushlow K., Olsen K., Steigler G., Payne S. L., Montelaro R. C., Issel C. J. Lentivirus genomic organization: The complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology. 155:1986;309-321.
38. Salinovich O., Payne S. L., Montelaro R. C., Hussain K. A., Issel C. J., Schnorr K. L. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J. Virol. 57:1986;71-80.
39. Sellon D. C., Perry S. T., Coggins L., Fuller F. J. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes. J. Virol. 66:1992;5906-5913.
40. Trivedi P., Meyer K. K., Streblow D. N., Preuninger B. L., Schultz K. T., Pauza C. D. Selective amplification of simian immunodeficiency virus genotypes after intrarectal inoculation of rhesus monkeys. J. Virol. 68:1994;7649-7653.
41. Zheng Y., Nakaya T., Sentsui H., Kameoka M., Kishi M., Hagiwara K. T. H., Kono Y., Ikuta K. Insertions, duplications, and substitutions in restricted gp90 regions of equine infectious anemia virus during febrile episodes in experimentally infected horses. J. Gen. Virol. 78:1997a;807-820.
42. Zheng Y., Sentsui H., Nakaya T., Kono Y., Ikuta K. In vivo dynamics of equine infectious anemia virus emerging during febrile episodes: Insertions/duplications at the principal neutralizing domain. J. Virol. 71:1997b;5031-5039.